Lipella Pharmaceuticals (LIPO) Insider Trading & Ownership $0.57 -0.07 (-10.94%) As of 09/19/2025 03:36 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lipella Pharmaceuticals (NASDAQ:LIPO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage32.11%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$31.30KNumber OfInsiders Selling(Last 3 Years)0 Get LIPO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lipella Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LIPO Insider Buying and Selling by Quarter Lipella Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/14/2024Jonathan H KaufmanInsiderBuy1,250$6.08$7,600.00 3/18/2024Jonathan H KaufmanInsiderBuy3,750$6.32$23,700.00 (Data available from 1/1/2013 forward) LIPO Insider Trading Activity - Frequently Asked Questions Who is on Lipella Pharmaceuticals' Insider Roster? The list of insiders at Lipella Pharmaceuticals includes Jonathan H Kaufman. Learn more on insiders at LIPO. What percentage of Lipella Pharmaceuticals stock is owned by insiders? 32.11% of Lipella Pharmaceuticals stock is owned by insiders. Learn more on LIPO's insider holdings. Which Lipella Pharmaceuticals insiders have been buying company stock? The following insider purchased LIPO shares in the last 24 months: Jonathan H Kaufman ($31,300.00). How much insider buying is happening at Lipella Pharmaceuticals? Insiders have purchased a total of 5,000 LIPO shares in the last 24 months for a total of $31,300.00 bought. Lipella Pharmaceuticals Key ExecutivesDr. Jonathan Kaufman M.B.A. (Age 57)Ph.D., Co-Founder, Chairman, CEO, President, Secretary & Treasurer Compensation: $204.13kDr. Michael B. Chancellor M.D. (Age 65)Co-Founder, Chief Medical Officer & Director Compensation: $195.83kMr. Douglas Johnston CPA (Age 39)Chief Financial Officer Compensation: $185kMs. Michele GruberDirector of OperationsKatie JohnstonController More Insider Trading Tools from MarketBeat Related Companies HOOK Insider Buying PCSA Insider Buying BCDA Insider Buying RNAZ Insider Buying CELZ Insider Buying ERNA Insider Buying INAB Insider Buying EPIX Insider Buying GNPX Insider Buying KPRX Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NASDAQ:LIPO) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipella Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipella Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.